Combination versus sequential cytotoxic chemotherapy in recurrent ovarian cancer: time for an evidence-based comparison.
Markman
Maurie
M
Department of Gynecologic Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. mmarkman@mdanderson.org
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D004334:Drug Administration Schedule; D019317:Evidence-Based Medicine; D005260:Female; D006801:Humans; D009944:Organoplatinum Compounds / Q000008:administration & dosage; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D043823:Taxoids / Q000008:administration & dosage
D009944:Organoplatinum Compounds; D043823:Taxoids